NEW YORK, Dec. 19, 2014 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) announced that trading of Juno Therapeutics (Nasdaq:JUNO), a biopharmaceutical company, commenced on The Nasdaq Stock Market on December 19, 2014.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=29746
Juno Therapeutics is a biopharmaceutical company focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer. Founded on a vision of using human cells as therapeutic tools, Juno aims to leverage its cell-based platform to develop immunotherapy drug candidates that address a broad range of cancers and human diseases.
"Juno Therapeutics is continually innovating in the field of cancer treatment and research," said Nelson Griggs, Executive Vice President, Listing Services, Nasdaq. "We are pleased to welcome Juno to the Nasdaq family of listed-companies and we look forward to celebrating many milestones with the Company in the years to come."
By listing with Nasdaq, Juno Therapeutics joins many of the world's largest and most revolutionary companies. Nasdaq has been the exchange of choice to 93 percent of healthcare companies that listed in the U.S. in 2014.
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $8.8 trillion and more than 10,000 corporate clients. To learn more, visit www.business.nasdaq.com.
The photo is also available via AP PhotoExpress.
CONTACT: Media Relations Contacts: Will Briganti (646) 441-5012 firstname.lastname@example.org Christine Barna (646) 441-5310 Christine.Barna@nasdaq.com